Giorgio V. Scagliotti

Research interests

Publications

• Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

  Cancer Discovery · 2023 · https://doi.org/10.1158/2159-8290.cd-22-1420

• Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study

  The Lancet Oncology · 2022 · https://doi.org/10.1016/s1470-2045(21)00660-4

• The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015

  Journal of Thoracic Oncology · 2021 · 10.1016/j.jtho.2021.11.003

• Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial

  The Lancet Oncology · 2021 · https://doi.org/10.1016/s1470-2045(21)00376-4

• Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer

  Journal of Thoracic Oncology · 2021 · https://doi.org/10.1016/j.jtho.2021.06.017

• IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy

  Journal of Thoracic Oncology · 2020 · https://doi.org/10.1016/j.jtho.2020.01.005

• Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

  The Lancet Oncology · 2020 · https://doi.org/10.1016/s1470-2045(20)30541-6

• Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations

  Journal of Thoracic Oncology · 2020 · https://doi.org/10.1016/j.jtho.2020.03.006

• Definition of Synchronous Oligometastatic Non–Small Cell Lung Cancer—A Consensus Report

  Journal of Thoracic Oncology · 2019 · https://doi.org/10.1016/j.jtho.2019.07.025

• Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC

  Journal of Thoracic Oncology · 2018 · https://doi.org/10.1016/j.jtho.2018.05.030

• Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial

  The Lancet · 2017 · https://doi.org/10.1016/s0140-6736(17)32365-6

• Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial

  The Lancet Oncology · 2017 · https://doi.org/10.1016/s1470-2045(17)30339-x

• Scientific Advances in Lung Cancer 2015

  Journal of Thoracic Oncology · 2016 · https://doi.org/10.1016/j.jtho.2016.03.012

• Lung cancer: current therapies and new targeted treatments

  The Lancet · 2016 · https://doi.org/10.1016/s0140-6736(16)30958-8

• Adjuvant chemotherapy for resected early-stage non-small cell lung cancer

  Cochrane Database of Systematic Reviews · 2015 · https://doi.org/10.1002/14651858.cd011430

• Phase III Multinational, Randomized, Double-Blind, Placebo-Controlled Study of Tivantinib (ARQ 197) Plus Erlotinib Versus Erlotinib Alone in Previously Treated Patients With Locally Advanced or Metastatic Nonsquamous Non–Small-Cell Lung Cancer

  Journal of Clinical Oncology · 2015 · https://doi.org/10.1200/jco.2014.60.7317

• Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer: A Phase III Trial

  Journal of Clinical Oncology · 2012 · https://doi.org/10.1200/jco.2011.39.2993

• Overall Survival Improvement in Patients with Lung Cancer and Bone Metastases Treated with Denosumab Versus Zoledronic Acid: Subgroup Analysis from a Randomized Phase 3 Study

  Journal of Thoracic Oncology · 2012 · https://doi.org/10.1097/jto.0b013e31826aec2b

• Aflibercept and Docetaxel Versus Docetaxel Alone After Platinum Failure in Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer: A Randomized, Controlled Phase III Trial

  Journal of Clinical Oncology · 2012 · https://doi.org/10.1200/jco.2012.42.6932

• International, Randomized, Placebo-Controlled, Double-Blind Phase III Study of Motesanib Plus Carboplatin/Paclitaxel in Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer: MONET1

  Journal of Clinical Oncology · 2012 · https://doi.org/10.1200/jco.2011.41.4987

• International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

  Journal of Thoracic Oncology · 2011 · https://doi.org/10.1097/jto.0b013e318206a221

• Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma

  Journal of Clinical Oncology · 2011 · https://doi.org/10.1200/jco.2010.31.3304

• Phase III Study of Carboplatin and Paclitaxel Alone or With Sorafenib in Advanced Non–Small-Cell Lung Cancer

  Journal of Clinical Oncology · 2010 · https://doi.org/10.1200/jco.2009.26.1321

• Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer

  Journal of Clinical Oncology · 2008 · https://doi.org/10.1200/jco.2007.15.0375

• Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

  Journal of Clinical Oncology · 2008 · https://doi.org/10.1200/jco.2007.13.9030

• Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase

  Cancer · 2006 · https://doi.org/10.1002/cncr.22208

• Prevalence of adrenal incidentaloma in a contemporary computerized tomography series

  Journal of Endocrinological Investigation · 2006 · https://doi.org/10.1007/bf03344099

• ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine

  Annals of Oncology · 2006 · https://doi.org/10.1093/annonc/mdl300

• Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1

  Journal of Clinical Oncology · 2004 · https://doi.org/10.1200/jco.2004.08.001

Current projects

No projects listed.